Skip to Main Content

Paper Details

Potential Therapeutic Targets and Promising Agents for Combating NAFLD.
Biomedicines
3
2022
NAFLD, NASH, Nonalcoholic fatty liver disease, dyslipidemia, fibrosis, hepatic necrosis, hepatic stellate cells, hypertension, inflammation, liver cancer, liver cirrhosis, nonalcoholic steatohepatitis, obesity, patients, steatosis, type 2 diabetes mellitus, viral hepatitis
Author NameAffiliation
Atsushi UmemuraKyoto Prefectural University of Medicine
Atsushi UmemuraKyoto Prefectural University of Medicine
Kanji YamaguchiKyoto Prefectural University of Medicine
Yoshito ItohKyoto Prefectural University of Medicine
  • 1 - 4

Datasets

Release 1.2